Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
147,479,114
-
Shares change
-
-490,442
-
Total reported value, excl. options
-
$4,794,596,759
-
Value change
-
-$48,097,035
-
Put/Call ratio
-
72%
-
Number of buys
-
181
-
Number of sells
-
147
-
Price
-
$32.51
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2025
As of 30 Jun 2025 Vaxcyte, Inc. - COMMON STOCK (PCVX) had 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 147,479,114 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, and Paradigm Biocapital Advisors LP.
This table shows 293 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.